Contents Issue 102 • January 2021 In association with Pharma in the age of Biden With President-elect Joe Biden set to take office in January, how will his administration approach the pharma industry? IN DEPTH Brexit: preventing counterfeit drugs Comment IDMP: What lies ahead? Briefing Industry news Pharma industry briefing Covid-19 briefing Comment Pipeline agents in the RA market The rising role of the microbiome in R&D IMDP: the benefit of hindsight In Depth Solving the puzzle of Hepatitis C Is self-medication the future of pharma? How do you fast-track a vaccine? Healthcare’s sustainability goals New Zealand: a promising trial destination In Data Inside the deal Deals analysis Market data 12/17/2020 15:06:39
Comment
IDMP: What lies ahead?